Clinical Trial: Study to Evaluate Efficacy When Transitioning From a Current Disease Modifying Therapy (DMT) to Ublituximab
Study Status: Completed
Recruit Status: RECRUITING
Condition: Relapsing Multiple Sclerosis
Study Type: INTERVENTIONAL
Official Title: Evaluating Efficacy When Transitioning From a Current Disease Modifying Therapy (DMT) to Ublituximab (ENHANCE)
Brief Summary:
The primary purpose of this phase 3b study is to assess efficacy after transition from a current DMT to ublituximab, as measured by T1 Gadolinium (Gd)-enhancing lesions.
Read more